Concepedia

Wenxin Xu

WX

39

Publications

4.6K

Citations

26

H-Index

1993

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Beth Israel Deaconess Medical Center

Massachusetts General Hospital

Wenxin Xu is an author at Dana-Farber Cancer Institute specializing in medicine, immunology, and immunotherapy.

Top concepts

MedicineImmunologyImmunotherapyOncologyPathologyCell DeathEngineeringCell BiologyTumor ImmunityCancer Research

Publications per year

1993–2024

39

Publications

39

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah et al. · The Lancet · 2020 · 1.8K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +11

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma

David A. Braun, Kelly Street, Kelly P. Burke et al. · Cancer Cell · 2021 · 483 citations · Full text

Progressive Immune Dysfunction, Urology, Cancer Immunosurveillance +12

Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models

Peter R. Rhode, Jack O. Egan, Wenxin Xu et al. · Cancer Immunology Research · 2015 · 220 citations · Full text

Immunoediting, Immunology, Immune Regulation +19

Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor αSu/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma

Wenxin Xu, Monica Jones, Bai Liu et al. · Cancer Research · 2013 · 190 citations · Full text

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19

Michael A. Thompson, Jeffrey P. Henderson, Pankil Shah et al. · JAMA Oncology · 2021 · 184 citations · Full text

Rows per page

1–5 of 39